Source:http://linkedlifedata.com/resource/pubmed/id/19018802
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2009-8-25
|
pubmed:abstractText |
1. Although it is well known that the combined administration of synthetic or plant-originated opioids with cannabinoids (CB) results in synergistic antinociception, the effects of combined administration of endogenous ligands acting at micro-opioid and CB receptors are not known. The aim of the present study was to determine the interaction between anandamide (AEA; a CB(1) receptor agonist) and endomorphin-1 (EM-1; a micro-opioid receptor agonist) after intrathecal administration. 2. Nociception was assessed by the paw-withdrawal test after carrageenan-induced inflammation in male Wistar rats. 3. Endomorphin-1 (16.4 pmol to 16.4 nmol) and AEA (4.3-288 nmol) alone dose-dependently decreased carrageenan-induced thermal hyperalgesia, although the highest dose of AEA also exhibited pain-inducing potential. The potency of AEA was approximately 59-fold lower than that of EM-1 (35% effective dose (ED(35)) 194.4 vs 3.3 nmol, respectively). Coadministration of these ligands revealed that combinations of 16.4 pmol EM-1 plus 28.8 or 86.5 nmol AEA were more effective than either drug alone, but other combinations were no more effective than the administration of EM-1 itself. Therefore, coadministration of AEA did not significantly shift the dose-response curve to EM-1. 4. The results of the present study indicate that the coadministration of AEA and EM-1 results in potentiated antihyperalgesia only for a combination of specific doses. Because AEA activates other receptor types (e.g. TRPV1) in addition to CB(1) receptors, the results of the present suggest that, after the coadministration of EM-1 and AEA, complex interactions ensue that may lead to different outcomes compared with those seen following the injection of exogenous ligands.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Analgesics,
http://linkedlifedata.com/resource/pubmed/chemical/Arachidonic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Carrageenan,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations,
http://linkedlifedata.com/resource/pubmed/chemical/Oligopeptides,
http://linkedlifedata.com/resource/pubmed/chemical/Polyunsaturated Alkamides,
http://linkedlifedata.com/resource/pubmed/chemical/anandamide,
http://linkedlifedata.com/resource/pubmed/chemical/endomorphin 1
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1440-1681
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
400-5
|
pubmed:meshHeading |
pubmed-meshheading:19018802-Analgesics,
pubmed-meshheading:19018802-Animals,
pubmed-meshheading:19018802-Arachidonic Acids,
pubmed-meshheading:19018802-Carrageenan,
pubmed-meshheading:19018802-Drug Combinations,
pubmed-meshheading:19018802-Drug Evaluation, Preclinical,
pubmed-meshheading:19018802-Drug Interactions,
pubmed-meshheading:19018802-Hyperalgesia,
pubmed-meshheading:19018802-Inflammation,
pubmed-meshheading:19018802-Injections, Spinal,
pubmed-meshheading:19018802-Male,
pubmed-meshheading:19018802-Oligopeptides,
pubmed-meshheading:19018802-Pain,
pubmed-meshheading:19018802-Polyunsaturated Alkamides,
pubmed-meshheading:19018802-Rats,
pubmed-meshheading:19018802-Rats, Wistar,
pubmed-meshheading:19018802-Spine,
pubmed-meshheading:19018802-Time Factors
|
pubmed:year |
2009
|
pubmed:articleTitle |
Antinociceptive interactions between anandamide and endomorphin-1 at the spinal level.
|
pubmed:affiliation |
Department of Physiology, Faculty of Medicine, University of Szeged, Szeged, Hungary.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|